Mutations in the splicing factor gene SRSF2 were notably rich in RAEB in our study and might negatively affect prognosis based on previous studies [30], different from a report of favorable prognosis by Bejar et al. [24]. This evidence concerns the gene SRSF2 and myelodysplastic syndrome with excess blasts.